Ever Source Wealth Advisors, LLC Beam Therapeutics Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.48 Billion
- Q3 2024
A detailed history of Ever Source Wealth Advisors, LLC transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 61 shares of BEAM stock, worth $1,634. This represents 0.0% of its overall portfolio holdings.
Number of Shares
61
Previous 48
27.08%
Holding current value
$1,634
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding BEAM
# of Institutions
235Shares Held
75.1MCall Options Held
438KPut Options Held
232K-
Farallon Capital Management LLC San Francisco, CA8.21MShares$220 Million1.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.84MShares$210 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.63MShares$205 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl6.53MShares$175 Million1.52% of portfolio
-
Arch Venture Management, LLC Chicago, IL4.83MShares$130 Million71.21% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $1.89B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...